Product Images Andexxa
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Andexxa NDC 0310-3200 by Astrazeneca Pharmaceuticals Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure - andexxa 01
figure a - andexxa 02
figure B - andexxa 03
figure II - andexxa 04
figure a 14 - andexxa 05
This appears to be a chart or table with headings for different treatments or interventions (Placebo bolus and ANDEXKA) and the number of individuals in each group (8 and 23, respectively). The chart also includes time points (in hours) after an initial bolus dose of each treatment, followed by "End of Bolus" and "End of Infusion" labels. However, the actual data in the table (represented by the string of numbers) is not available or readable.*
figure b 14 - andexxa 06
carton 200mg mL - andexxa 07
The text describes Andexxa, a powder for solution that contains coagulation factor Xa (recombinant), inactivated-zhzo. It comes in four single-dose vials and must be stored refrigerated. After reconstitution, each vial contains 200 mg coagulation factor Xa (recombinant), inactivated-zhzo, tris base, trs hydrochloride, L-arginine hydrochloride, sucrose, mannitol, and polysorbate 80. The dosage and administration information can be found in the enclosed package insert. It is manufactured by AstraZeneca AB in Sweden and distributed by AstraZeneca Pharmaceuticals LP in Wilmington, Delaware.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.